AUPH vs SRE · P/E 28, rev $160.9M vs P/E 31, rev $13.70B
Aurinia Pharmaceuticals Inc (AUPH) versus Sempra Energy (SRE) — a side-by-side from cached financials, not a winner call.
Aurinia Pharmaceuticals Inc (AUPH) is a biotechnology company listed on US.
Sempra Energy (SRE) is a utilities - diversified company listed on US.
Latest reported AUPH revenue for 2026-06-30 was $160.9M. Net income was $71.8M. AUPH currently screens at market cap $1.03B and trailing P/E 28.1.
Latest reported SRE revenue for 2025-12-31 was $13.70B. Net income was $1.84B. Revenue was up 3.9% from 2024-12-31 to 2025-12-31. SRE currently screens at market cap $59.76B and trailing P/E 31.1.
AUPH currently screens at market cap $1.03B and trailing P/E 28.1. SRE currently screens at market cap $59.76B and trailing P/E 31.1.
Not investment advice. Open the AUPH and SRE stock pages for the full models.
Not investment advice.